Symptoms can look similar but be completely different diseases
For the second time in weeks, São Paulo finds itself at the threshold of a question that carries enormous weight: is the Ebola virus present on Brazilian soil? A 31-year-old woman who returned from one of the world's most active outbreak zones now rests in isolation at the Emilio Ribas Institute, her fate — and the city's next steps — suspended in the interval between symptom and diagnosis. The case is a reminder that in an interconnected world, the boundaries between distant crises and local realities are thinner than we imagine.
- A Brazilian woman who worked in North Kivu, eastern Congo, developed fever and diarrhea just three days after landing in São Paulo, triggering immediate Ebola protocols.
- She was swiftly transferred to the Emilio Ribas Institute under strict isolation, her case meeting the official criteria for suspected Ebola: recent travel to an active transmission zone plus compatible symptoms.
- The city is still processing the memory of its first Ebola scare this month — a Congolese man who deteriorated so severely he required intubation, only for tests to confirm meningococcal meningitis instead.
- Unlike that first patient, this woman remains clinically stable, though the diagnostic uncertainty is the same: laboratory results from the Adolfo Lutz Institute are still pending.
- São Paulo's health system is holding the line — isolating, testing, and waiting — demonstrating that its biosafety infrastructure can absorb the pressure of repeated high-stakes investigations.
São Paulo health authorities opened an investigation Wednesday into a second suspected Ebola case: a 31-year-old Brazilian woman who had traveled to North Kivu province in eastern Congo for work. She returned to Brazil on June 6 and developed fever and diarrhea three days later, prompting a private clinic to alert authorities. By early Wednesday morning, she had been transferred to the Emilio Ribas Institute of Infectious Diseases under strict isolation protocols.
The suspicion was triggered because she met the established criteria — recent travel to a region with active Ebola transmission and symptoms consistent with the virus. She tested negative for malaria and her condition is currently stable, but laboratory confirmation from the Adolfo Lutz Institute is still pending.
The case arrives just over a week after São Paulo navigated its first Ebola scare of the season. A 37-year-old Congolese man had been hospitalized at the same institute with diarrhea, disorientation, and severe clinical deterioration requiring intubation. On May 31, the Adolfo Lutz Institute confirmed he had meningococcal meningitis — a bacterial disease that can mimic early Ebola symptoms closely enough to demand the same rigorous differential diagnosis.
The contrast between the two cases is notable: the first patient's condition worsened dramatically before a diagnosis was reached, while the current patient remains stable. Still, São Paulo's health system is applying the same exacting protocol regardless. The next chapter belongs to the laboratory.
São Paulo's health authorities opened an investigation on Wednesday into a second suspected case of Ebola in the state capital. The patient is a 31-year-old Brazilian woman who returned from the Democratic Republic of Congo and developed symptoms consistent with the virus.
According to the state health department, the woman traveled to North Kivu province in eastern Congo for work and landed back in Brazil on Saturday, June 6. Three days later, on Tuesday, June 9, she developed fever and diarrhea and sought care at a private medical clinic. The clinic reported her case to health authorities, who transferred her to the Emilio Ribas Institute of Infectious Diseases early Wednesday morning under strict isolation protocols.
The investigation was initiated because the patient met the specific criteria for a suspected Ebola case: recent travel to a region with active disease transmission and the presence of symptoms consistent with the virus. She tested negative for malaria, and her clinical condition remains stable. However, there is no laboratory confirmation yet. The Adolfo Lutz Institute is conducting the diagnostic analysis.
This case comes just over a week after health authorities ruled out a previous Ebola suspicion in a 37-year-old man from the Congo who was also hospitalized at Emilio Ribas. That patient presented with diarrhea, disorientation, and clinical deterioration severe enough to require intubation. On May 31, laboratory testing confirmed he had meningococcal meningitis, not Ebola. Regiane de Paula, coordinator of disease control for the health department, confirmed the bacterial diagnosis through testing at the Adolfo Lutz Institute.
The distinction matters because both diseases can present with overlapping symptoms in their early stages, making differential diagnosis essential. The first patient's condition worsened significantly before meningitis was confirmed. The current case, by contrast, shows clinical stability so far, though investigators are following the same rigorous protocol.
São Paulo's health system has now demonstrated its capacity to identify, isolate, and investigate suspected cases of a disease that carries significant public health weight. The state is operating under established biosafety procedures designed for exactly this scenario. What happens next depends on laboratory results from the Adolfo Lutz Institute, which will determine whether this woman is carrying the Ebola virus or whether her symptoms point to another diagnosis entirely.
Notable Quotes
The investigation was initiated because the patient met specific criteria for a suspected Ebola case, including recent travel to a region with active disease transmission and symptoms consistent with the virus.— São Paulo State Health Department
There is confirmation of the bacterium causing meningococcal meningitis through the Adolfo Lutz Institute, as part of the differential diagnosis process.— Regiane de Paula, coordinator of disease control
The Hearth Conversation Another angle on the story
Why does a single case in São Paulo warrant this level of investigation and isolation?
Because Ebola has a fatality rate that can exceed 50 percent, and the woman met the clinical and epidemiological criteria that trigger mandatory investigation—she was in an active transmission zone and developed symptoms within the incubation window.
How confident are health officials that this is actually Ebola?
They're not confident at all yet. That's why she's isolated. The symptoms—fever, diarrhea—could be many things. The lab work will tell them what they're actually dealing with.
The first suspected case turned out to be meningitis. Does that make people less worried about the second one?
It should make them more careful, not less worried. It shows that symptoms can look similar but be completely different diseases. That's exactly why isolation and testing matter.
How long does it typically take to get a lab result for Ebola?
The source doesn't specify, but these tests are usually prioritized. The Adolfo Lutz Institute knows what's at stake. Days, not weeks.
What happens to the patient if it comes back negative?
She goes home. She was never in danger of being held indefinitely. The isolation is precautionary, not punitive. If it's not Ebola, they figure out what it is and treat accordingly.
Is there any chance this spreads beyond her?
Not if the isolation protocols hold. That's the entire point of catching it early and moving her to a specialized facility. The system is designed to prevent exactly that.